Clinical Trials Insight: 700018927

Trial Profile

Clinical Trials Insight: 700018927

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2014

At a glance

  • Drugs Odanacatib (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 06 Apr 2007 Status changed from suspended to discontinued, according to ClinicalTrials.gov.
    • 01 Apr 2007 Status changed from recruiting to suspended, according to ClinicalTrials.gov.
    • 23 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top